Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Plos One|March 17, 2017
Correction: Age Targeting of Voluntary Medical Male Circumcision Programs Using the Decision Makers' Program Planning Toolkit (DMPPT) 2.0Katharine Kripke, Marjorie Opuni, Melissa Schnure, et al.
Sexually Transmitted Diseases|March 19, 2026
Trends in Triple-Site Testing for Chlamydia and Gonorrhea in New York City: A Cross-sectional Study Using Health Information Exchange DataEmma Tucker, Harry Reyes Nieva, Delivette Castor, et al.
Plos One|May 8, 2014
Costs and impacts of scaling up voluntary medical male circumcision in TanzaniaVeena Menon, Elizabeth Gold, Ramona Godbole, et al.
Medrxiv : the Preprint Server for Health Sciences|April 22, 2024
Enabling a Learning Public Health System: Enhanced Surveillance of HIV and Other Sexually Transmitted InfectionsHarry Reyes Nieva, Jason Zucker, Emma Tucker, et al.
BMC Medicine|October 10, 2025
STI testing and diagnosis rates among patients with Mpox in 2 populous US cities, 2022Shauna H Gunaratne, Karen J Vigil, Simian Huang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2013
Steady-state pharmacokinetics, cord blood concentrations, and safety of ritonavir-boosted fosamprenavir in pregnancyMichelle S Cespedes, Delivette Castor, Susan L Ford, et al.
Plos One|July 14, 2016
Voluntary Medical Male Circumcision for HIV Prevention in Malawi: Modeling the Impact and Cost of Focusing the Program by Client Age and GeographyKatharine Kripke, Frank Chimbwandira, Zebedee Mwandi, et al.
Plos One|January 4, 2017
Correction: Voluntary Medical Male Circumcision for HIV Prevention in Malawi: Modeling the Impact and Cost of Focusing the Program by Client Age and GeographyKatharine Kripke, Frank Chimbwandira, Zebedee Mwandi, et al.
International Journal of Environmental Research and Public Health|October 14, 2020
Immediate Antiretroviral Therapy: The Need for a Health Equity ApproachOfole Mgbako, Magdalena E Sobieszczyk, Susan Olender, et al.
Antimicrobial Agents and Chemotherapy|August 5, 2009
Natural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitorsAndrea Low, Nicole Prada, Michael Topper, et al.
Pageof 10